Brief: Hamlet Pharma Gets Patent Granted In Europe
17/11/2020 13:59
Nov 17 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* NEUTRACEUTICAL PATENT GRANTED IN EUROPE
* PATENT IS VALID UNTIL AUGUST 8, 2033
Source text for Eikon: ID:nWkr8ZS72B
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe